Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amphastar Pharmaceuticals

26.61
-0.6300-2.31%
Post-market: 26.40-0.2100-0.79%18:48 EDT
Volume:699.45K
Turnover:18.49M
Market Cap:1.27B
PE:8.70
High:27.02
Open:26.34
Low:26.14
Close:27.24
Loading ...

International Medication Systems, Ltd. Receives FDA's Drug Shortage Assistance Award

ACCESS Newswire
·
28 Mar

Amphastar Pharmaceuticals Is Maintained at Neutral by Piper Sandler

Dow Jones
·
21 Mar

On Nasdaq, I Prefer the Less-Famous Stocks

GuruFocus.com
·
18 Mar

Q4 Earnings Highs And Lows: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs The Rest Of The Generic Pharmaceuticals Stocks

StockStory
·
13 Mar

Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference

ACCESS Newswire
·
05 Mar

Generic Pharmaceuticals Stocks Q4 In Review: Amneal (NASDAQ:AMRX) Vs Peers

StockStory
·
05 Mar

Amphastar Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.
·
01 Mar

Is Amphastar Pharmaceuticals, Inc. (AMPH) the Best Small Cap Pharma Stocks to Buy Now?

Insider Monkey
·
01 Mar

Amphastar price target lowered to $36 from $44 at BofA

TIPRANKS
·
01 Mar

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds

Benzinga
·
01 Mar

Amphastar Pharmaceuticals Inc (AMPH) Q4 2024 Earnings Call Highlights: Revenue Growth and ...

GuruFocus.com
·
01 Mar

Amphastar (AMPH) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks
·
28 Feb

Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates

Zacks
·
28 Feb

Amphastar: Q4 Earnings Snapshot

Associated Press Finance
·
28 Feb

Stock Track | Amphastar Pharmaceuticals Plunges 10% After Q4 Earnings Miss on Higher Costs

Stock Track
·
28 Feb

Amphastar Pharma Q4 2024 Adj. EPS $0.92 Misses $0.94 Estimate, Sales $186.500M Miss $188.810M Estimate

Benzinga
·
28 Feb

Amphastar Pharmaceuticals Q4 EPS USD 0.74

THOMSON REUTERS
·
28 Feb

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024

ACCESS Newswire
·
28 Feb

Earnings To Watch: Amphastar Pharmaceuticals (AMPH) Reports Q4 Results Tomorrow

StockStory
·
26 Feb

Q3 Earnings Outperformers: Viatris (NASDAQ:VTRS) And The Rest Of The Generic Pharmaceuticals Stocks

StockStory
·
21 Feb